Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis
Critical Care2011Vol. 15(3), pp. R149–R149
Citations Over TimeTop 1% of 2011 papers
Allison J. Sutherland, Mervyn Thomas, Roslyn A. Brandon, Richard B. Brandon, Jeffrey Lipman, Benjamin Tang, Anthony S. McLean, Ranald Pascoe, Gareth Price, Thu Thuy Nguyen, Glenn Stone, Deon J. Venter
Abstract
This novel molecular biomarker test has a clinically relevant sensitivity and specificity profile, and has the capacity for early detection of sepsis via the monitoring of critical care patients.
Related Papers
- → Liver in sepsis and systemic inflammatory response syndrome(2002)171 cited
- → Morphological changes in white blood cells in systemic inflammatory response syndrome (SIRS) with and without sepsis: An observational study(2023)6 cited
- → The Role of the Endothelium in Systemic Inflammatory Response Syndrome and Sepsis(2007)1 cited
- [Biochemical disturbances in patients with Systemic Inflammatory Response Syndrome (SIRS) and sepsis. Part I. Biochemical disturbances in patients with sepsis].(2005)
- → Applications of proteomics in SIRS and sepsis(2011)